Deborah Keller

Laboratory Corporation of America has named Deborah Keller as the CEO of Covance Drug Development. She takes over for Joseph Herring who will retire on July 31 after more than a decade as CEO.

Keller joined Covance in 1987 and has held senior leadership roles in global operations, quality assurance, and marketing. Most recently she served as executive vice president of Covance and group president of R&D Laboratories where she led more than 6,000 employees at 18 facilities across the globe.  

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

 Senator Lamar Alexander (R-Tenn.), who chairs the Senate health committee, will be retiring at the end of his term, Stat News reports.

UCSF researchers find that having two X chromosomes may contribute to women's longer lifespans, according to Discover's D-brief blog.

The Wall Street Journal reports on the US Centers for Disease Control and Prevention's use of genetic approaches to study foodborne illnesses.

In PNAS this week: immune cell profiling of wild baboons by social status, metabolomics profiling of esophageal tumors, and more.